Jason H. Gill

GW9662, a potent antagonist of PPAR<i>γ</i>, inhibits growth of breast tumour cells and promotes the anticancer effects of the PPAR<i>γ</i> agonist rosiglitazone, independently of PPAR<i>γ</i> activation

Jill M. Seargent, Elisabeth Yates, Jason H. Gill · British Journal of Pharmacology · 2004 · 188 citations · Full text

Medicine, Oncology, Pharmacology +15

Micro‐RNA‐31 controls hair cycle‐associated changes in gene expression programs of the skin and hair follicle

Andrei N. Mardaryev, Mohammed I. Ahmed, Nikola Vlahov et al. · The FASEB Journal · 2010 · 181 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas

Iduna Fichtner, W. Slisow, Jason H. Gill et al. · European Journal of Cancer · 2003 · 154 citations

Medicine, Cancer Biology, Oncology +16

Development of Novel Tumor‐Targeted Theranostic Nanoparticles Activated by Membrane‐Type Matrix Metalloproteinases for Combined Cancer Magnetic Resonance Imaging and Therapy

Celina Ansari, Grigory Tikhomirov, Su Hyun Hong et al. · Small · 2013 · 154 citations · Full text

Medicine, Oncology, Pharmacology +17

Non-genotoxic hepatocarcinogenesis stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations

Ruth Roberts, Anthony R. Soames, Jason H. Gill et al. · Carcinogenesis · 1995 · 97 citations

Pharmacy, Pharmacology, Toxicology +16